Center-Authored Papers

Filters: Author is Ostrander, Elaine A  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
2008
Schaid DJ, McDonnell SK, Carlson EE, Thibodeau SN, Stanford JL, Ostrander EA.  2008.  Searching for epistasis and linkage heterogeneity by correlations of pedigree-specific linkage scores.. Genetic epidemiology. 32(5):464-75. Abstract
Fitzgerald LM, Agalliu I, Johnson K, Miller MA, Kwon EM, Hurtado-Coll A, Fazli L, Rajput AB, Gleave ME, Cox ME et al..  2008.  Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer.. BMC cancer. 8:230. Abstract
Salinas CA, Kwon E, Carlson CS, Koopmeiners JS, Feng Z, Karyadi DM, Ostrander EA, Stanford JL.  2008.  Multiple independent genetic variants in the 8q24 region are associated with prostate cancer risk.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 17(5):1203-13. Abstract
Pierce BL, Plymate S, Ostrander EA, Stanford JL.  2008.  Diabetes mellitus and prostate cancer risk.. The Prostate. 68(10):1126-32. Abstract
Agalliu I, Salinas CA, Hansten PD, Ostrander EA, Stanford JL.  2008.  Statin use and risk of prostate cancer: results from a population-based epidemiologic study.. American journal of epidemiology. 168(3):250-60. Abstract
Agalliu I, Suuriniemi M, Prokunina-Olsson L, Johanneson B, Collins FS, Stanford JL, Ostrander EA.  2008.  Evaluation of a variant in the transcription factor 7-like 2 (TCF7L2) gene and prostate cancer risk in a population-based study.. The Prostate. 68(7):740-7. Abstract
Kote-Jarai Z, Easton DF, Stanford JL, Ostrander EA, Schleutker J, Ingles SA, Schaid D, Thibodeau S, Dörk T, Neal D et al..  2008.  Multiple novel prostate cancer predisposition loci confirmed by an international study: the PRACTICAL Consortium.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 17(8):2052-61. Abstract
Holt SK, Karyadi DM, Kwon EM, Stanford JL, Nelson PS, Ostrander EA.  2008.  Association of megalin genetic polymorphisms with prostate cancer risk and prognosis.. Clinical cancer research : an official journal of the American Association for Cancer Research. 14(12):3823-31. Abstract
Tischkowitz MD, Yilmaz A, Chen LQ, Karyadi DM, Novak D, Kirchhoff T, Hamel N, Tavtigian SV, Kolb S, Bismar TA et al..  2008.  Identification and characterization of novel SNPs in CHEK2 in Ashkenazi Jewish men with prostate cancer.. Cancer letters. 270(1):173-80. Abstract
Johanneson B, McDonnell SK, Karyadi DM, Hebbring SJ, Wang L, Deutsch K, McIntosh L, Kwon EM, Suuriniemi M, Stanford JL et al..  2008.  Fine mapping of familial prostate cancer families narrows the interval for a susceptibility locus on chromosome 22q12.3 to 1.36 Mb.. Human genetics. 123(1):65-75. Abstract
2009
Udler MS, Meyer KB, Pooley KA, Karlins E, Struewing JP, Zhang J, Doody DR, MacArthur S, Tyrer J, Pharoah PD et al..  2009.  FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation.. Human molecular genetics. 18(9):1692-703. Abstract
Fitzgerald LM, Kwon EM, Koopmeiners JS, Salinas CA, Stanford JL, Ostrander EA.  2009.  Analysis of recently identified prostate cancer susceptibility loci in a population-based study: associations with family history and clinical features.. Clinical cancer research : an official journal of the American Association for Cancer Research. 15(9):3231-7. Abstract
Harris JN, Bowen DJ, Kuniyuki A, McIntosh L, Fitzgerald LM, Ostrander EA, Stanford JL.  2009.  Interest in genetic testing among affected men from hereditary prostate cancer families and their unaffected male relatives.. Genetics in medicine : official journal of the American College of Medical Genetics. 11(5):344-55. Abstract
Eeles RA, Kote-Jarai Z, Al Olama AA, Giles GG, Guy M, Severi G, Muir K, Hopper JL, Henderson BE, Haiman CA et al..  2009.  Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.. Nature genetics. 41(10):1116-21. Abstract
Zhu Y, Stevens RG, Hoffman AE, Fitzgerald LM, Kwon EM, Ostrander EA, Davis S, Zheng T, Stanford JL.  2009.  Testing the circadian gene hypothesis in prostate cancer: a population-based case-control study.. Cancer research. 69(24):9315-22. Abstract
Stanford JL, Fitzgerald LM, McDonnell SK, Carlson EE, McIntosh LM, Deutsch K, Hood L, Ostrander EA, Schaid DJ.  2009.  Dense genome-wide SNP linkage scan in 301 hereditary prostate cancer families identifies multiple regions with suggestive evidence for linkage.. Human molecular genetics. 18(10):1839-48. Abstract
Salinas CA, Koopmeiners JS, Kwon EM, FitzGerald L, Lin DW, Ostrander EA, Feng Z, Stanford JL.  2009.  Clinical utility of five genetic variants for predicting prostate cancer risk and mortality.. The Prostate. 69(4):363-72. Abstract
Penney KL, Salinas CA, Pomerantz M, Schumacher FR, Beckwith CA, Lee G-S, Oh WK, Sartor O, Ostrander EA, Kurth T et al..  2009.  Evaluation of 8q24 and 17q risk loci and prostate cancer mortality.. Clinical cancer research : an official journal of the American Association for Cancer Research. 15(9):3223-30. Abstract
Holt SK, Kwon EM, Peters U, Ostrander EA, Stanford JL.  2009.  Vitamin D pathway gene variants and prostate cancer risk.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 18(6):1929-33. Abstract
2010
Christensen BG, Baffoe-Bonnie AB, George A, Powell I, Bailey-Wilson JE, Carpten JD, Giles GG, Hopper JL, Severi G, English DR et al..  2010.  Genome-wide linkage analysis of 1,233 prostate cancer pedigrees from the International Consortium for Prostate Cancer Genetics using novel sumLINK and sumLOD analyses.. The Prostate. 70(7):735-44. Abstract
Wright JL, Kwon EM, Lin DW, Kolb S, Koopmeiners JS, Feng Z, Ostrander EA, Stanford JL.  2010.  CYP17 polymorphisms and prostate cancer outcomes.. The Prostate. 70(10):1094-101. Abstract
Langeberg WJ, Kwon EM, Koopmeiners JS, Ostrander EA, Stanford JL.  2010.  Population-based study of the association of variants in mismatch repair genes with prostate cancer risk and outcomes.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 19(1):258-64. Abstract
Johanneson B, McDonnell SK, Karyadi DM, Quignon P, McIntosh L, Riska SM, Fitzgerald LM, Johnson G, Deutsch K, Williams G et al..  2010.  Family-based association analysis of 42 hereditary prostate cancer families identifies the Apolipoprotein L3 region on chromosome 22q12 as a risk locus.. Human molecular genetics. 19(19):3852-62. Abstract
Agalliu I, Kwon EM, Salinas CA, Koopmeiners JS, Ostrander EA, Stanford JL.  2010.  Genetic variation in DNA repair genes and prostate cancer risk: results from a population-based study.. Cancer causes & control : CCC. 21(2):289-300. Abstract
Salinas CA, Kwon EM, Fitzgerald LM, Feng Z, Nelson PS, Ostrander EA, Peters U, Stanford JL.  2010.  Use of aspirin and other nonsteroidal antiinflammatory medications in relation to prostate cancer risk.. American journal of epidemiology. 172(5):578-90. Abstract